Scout | NIH INCLUDE R61/R33 Funding to Develop Clinical Trials for Down Syndrome (Phased Awards)

nofo

NIH INCLUDE R61/R33 Funding to Develop Clinical Trials for Down Syndrome (Phased Awards)

NIH’s INCLUDE program is funding milestone-driven, exploratory/developmental clinical trial planning for treating critical co-occurring health conditions in people with Down syndrome. Awards use a two-phase structure: up to 2 years for the R61 stage, with possible transition to up to 3 years of R33 clinical trial support, for a total period of up to 5 years. Applicants must propose measurable …

Source

Agency: National Institutes of Health

Award

Total Funding: $3M

Dates

Open Date: May 13, 2026

Close Date: June 15, 2028

Eligibility

government

industry:research

nonprofit

small_business

tribal

university

For profit organizations other than small businesses

Native American tribal governments (Federally recognized)

Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education

Private institutions of higher education

State governments

Keywords

nih include

down syndrome

clinical trials

r61 r33

phased funding

milestone driven

co-occurring conditions

Supporting Links

Documents

Similar Opportunities

Unlock similar opportunities

Get the full picture on this opportunity

Create a free Scout account to unlock everything you need to decide fast and win the grant.

Instant Fit Analysis

Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
Deep agency & funder detail

Program context, sub-agency structure, and a full eligibility breakdown.
Source links & full documents

Jump straight to the solicitation and download every attachment.
Similar opportunities

Discover related funding matched to your work.

Get a Demo Sign Up

Already have an account? Sign In

Trusted by 500+ Happy Customers